Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients

Archives of Dermatological Research

Volumn 304, Issue 8, 2012, Pages 639-645

  Quaglino, P ^a   Antiga, E ^b   Comessatti, A ^a   Caproni, M ^b   Nardo T ^a   Ponti, R ^a   Novelli, M ^a   Osella Abate, S ^a   Fabbri, P ^b   Bernengo, M G ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Bullous pemphigoid; CCR4; FOXP3; Regulatory T cells

Indexed keywords

CD28 ANTIGEN; CHEMOKINE RECEPTOR CCR4; L SELECTIN; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; BULLOUS PEMPHIGOID; CD4+ CD25+ T LYMPHOCYTE; CD8+ CD28- T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

AGED; AGED, 80 AND OVER; ANTIGENS, CD4; BLOOD CIRCULATION; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84867578049     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-012-1213-9     Document Type: Article

References (39)

1. Antiga E, Del Bianco E, Difonzo E, Fabbri P, Caproni M (2011) Serum levels of the regulatory cytokines transforming growth factor-b and interleukin-10 are reduced in patients with discoid lupus erythematosus. Lupus 20(6):556-560
2. Antiga E, Kretz CC, Klembt R, Massi D, Ruland V, Stumpf C, Baroni G, Hartmann M, Hartschuh W, Volpi W, Del Bianco E, Enk A, Fabbri P, Krammer PH, Caproni M, Kuhn A (2010) Characterization of regulatory T cells in patients with dermatomyositis. J Autoimmun 35(4):342-350
3. Antiga E, Quaglino P, Bellandi S, Volpi W, Del Bianco E, Comessatti A, Osella-Abate S, De Simone C, Marzano A, Bernengo MG, Fabbri P, Caproni M (2010) Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea. Br J Dermatol 162(5):1056-1063
4. Arakawa M, Dainichi T, Ishii N, Hamada T, Karashima T, Nakama T, Yasumoto S, Tsuruta D, Hashimoto T (2011) Lesional Th17 cells and regulatory T cells in bullous pemphigoid. Exp Dermatol 20(12):1022-1024
5. Balashov KE, Khoury SJ, Hafler DA, Weiner HL (1995) Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis. J Clin Invest 95(6):2711-2719
6. Büdinger L, Borradori L, Yee C, Eming R, Ferencik S, Grosse-Wilde H, Merk HF, Yancey K, Hertl M (1998) Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest 102(12):2082-2089
7. Campbell JJ, O'Connell DJ, Wurbel MA. Cutting Edge (2007) Chemokine receptor CCR4 is necessary for antigen-driven cutaneous accumulation of CD4 T cells under physiological conditions. J Immunol 178(6):3358-3362
8. Chen R, Ning G, Zhao ML, Fleming MG, Diaz LA, Werb Z, Liu Z (2001) Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest 108(8):1151-1158
9. Colovai AI, Mirza M, Vlad G, Wang S, Ho E, Cortesini R, Suciu-Foca N (2003) Regulatory CD8+ CD28-T cells in heart transplant recipients. Hum Immunol 64(1):31-37
10. Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN (2007) Regulatory T cells and human disease. Clin Dev Immunol 2007:89195
11. Dvorak AM, Mihm MC Jr, Osage JE, Kwan TH, Austen KF, Wintroub BU (1982) Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient. J Invest Dermatol 78(2):91-101
12. Fagnoni FF, Vescovini R, Mazzola M, Bologna G, Nigro E, Lavagetto G, Franceschi C, Passeri M, Sansoni P (1996) Expansion of cytotoxic CD8+ CD28-T cells in healthy ageing people, including centenarians. Immunology 88(4):501-507
13. Filaci G, Bacilieri S, Fravega M, Monetti M, Contini P, Ghio M, Setti M, Puppo F, Indiveri F (2001) Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus. J Immunol 166:6452-6457
14. Filaci G, Fravega M, Negrini S, Procopio F, Fenoglio D, Rizzi M, Brenci S, Contini P, Olive D, Ghio M, Setti M, Accolla RS, Puppo F, Indiveri F (2004) Non antigen specific CD8+ T suppressor lymphocytes originate from CD8+ CD28-T cells and inhibit both T-cell proliferation and CTL function. Hum Immunol 65(2):142-156
15. Fu S, Yopp AC, Mao X, Chen D, Zhang N, Mao M, Ding Y, Bromberg JS (2004) CD4+ CD25+ CD62L+ T-regulatory cell subset has optimal suppressive and proliferative potential. Am J Transplant 4(1):65-78
16. Hirahara K, Liu L, Clark RA, Yamanaka K, Fuhlbrigge RC, Kupper TS (2006) The majority of human peripheral blood CD4+ CD25highFoxp3+ regulatory T cells bear functional skinhoming receptors. J Immunol 177:4488-4494
17. Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, D'Ambrosio D (2001) Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+ CD25+ regulatory T cells. J Exp Med 194:847-854
18. Jiang H, Chess L (2004) An integrated view of suppressor T cell subsets in immunoregulation. J Clin Invest 114:1198-1208
19. Jonuleit H, Schmitt E (2003) The regulatory T cell family: distinct subsets and their interrelations. J Immunol 171(12):6323-6327
20. Kmieciak M, Gowda M, Graham L, Godder K, Bear HD, Marincola FM, Manjili MH (2009) Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function. J Transl Med 7:89
21. Long SA, Buckner JH (2011) CD4+ FOXP3+ T Regulatory Cells in Human Autoimmunity: more than a numbers game. J Immunol 187(5):2061-2066
22. Mikulkova Z, Praksova P, Stourac P, Bednarik J, Strajtova L, Pacasova R, Belobradkova J, Dite P, Michalek J (2010) Numerical defects in CD8+ CD28-T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis. Cell Immunol 262(2):75-79
23. Möttönen M, Heikkinen J, Mustonen L, Isomäki P, Luukkainen R, Lassila O (2005) CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 140:360-367
24. Pfütze M, Niedermeier A, Hertl M, Eming R (2007) Introducing a novel autoimmune bullous skin disorder intensity score (ABSIS) in pemphigus. Eur J Dermatol. 17(1):4-11
25. Quaglino P, Comessatti A, Ponti R, Peroni A, Mola F, Fierro MT, Savoia P, Novelli M, Bernengo MG (2009) Reciprocal modulation of circulating CD4+ CD25+ bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients. Int J Immunopathol Pharmacol 22(2):353-362
26. Quaglino P, Ortoncelli M, Comessatti A, Ponti R, Novelli M, Bergallo M, Costa C, Cicchelli S, Savoia P, Bernengo MG (2009) Circulating CD4+ CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients. Dermatology 219(3):250-258
27. Rensing-Ehl A, Gaus B, Bruckner-Tuderman L, Martin SF (2007) Frequency, function and CLA expression of CD4+ CD25+ FOXP3+ regulatory T cells in bullous pemphigoid. Exp Dermatol 16(1):13-21
28. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155(3):1151-1164
29. Scotto L, Naiyer AJ, Galluzzo S, Rossi P, Manavalan JS, Kim-Schulze S, Fang J, Favera RD, Cortesini R, Suciu-Foca N (2004) Overlap between molecular markers expressed by naturally occurring CD4+ CD25+ regulatory T cells and antigen specific CD4+ CD25+ and CD8+ CD28-T suppressor cells. Hum Immunol 65:1297-1306
30. Simone R, Zicca A, Saverino D (2008) The frequency of regulatory CD3+ CD8+ CD28-CD25+ T lymphocytes in human peripheral blood increases with age. J Leukoc Biol 84(6):1454-1461
31. Sugiyama H, Matsue H, Nagasaka A, Nakamura Y, Tsukamoto K, Shibagaki N, Kawamura T, Kitamura R, Ando N, Shimada S (2007) CD4+ CD25high regulatory T cells are markedly decreased in blood of patients with pemphigus vulgaris. Dermatology 214(3):210-220
32. Tang AL, Teijaro JR, Njau MN, Chandran SS, Azimzadeh A, Nadler SG, Rothstein DM, Farber DL (2008) CTLA4 expression is an indicator and regulator of steady-state CD4+ FoxP3+ T cell homeostasis. J Immunol 181:1806-1813
33. Tang Q, Bluestone JA (2008) The FoxP3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 9:239-244
34. Tulunay A, Yavuz S, Direskeneli H, Eksioglu-Demiralp E (2008) CD8+ CD28-, suppressive T cells in systemic lupus erythematosus. Lupus 17(7):630-637
35. Veldman C, Höhne A, Dieckmann D, Schuler G, Hertl M (2004) Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris. J Immunol 172(10):6468-6475
36. Veldman C, Pahl A, Beissert S, Hansen W, Buer J, Dieckmann D, Schuler G, Hertl M (2006) Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells. J Immunol 176(5):3215-3222
37. Veldman C, Pahl A, Hertl M (2009) Desmoglein 3-specific T regulatory 1 cells consist of two subpopulations with differential expression of the transcription factor Foxp3. Immunology 127(1):40-49
38. Wintroub BU, Mihm MC Jr, Goetzl EJ, Soter NA, Austen KF (1978) Morphologic and functional evidence for release of mastcell products in bullous pemphigoid. N Engl J Med 298(8):417-421
39. Yokoyama T, Matsuda S, Takae Y, Wada N, Nishikawa T, Amagai M, Koyasu S (2011) Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris. Int Immunol 23(6):365-373